ASA: Worldwide Activity Report 2024

11 December 2024 - Corporate -

Whether it’s by taking part in Congresses and Fairs or organising on-site courses or webinars, once again in 2024 ASA has proved to be highly proactive in both the human and veterinary fields. 

This is clearly confirmed by the numbers that describe the company's commitment towards training and participation in international meetings: 
•    21 Conferences and fairs
•    43 training sessions held in person
•    15 webinars to support distributors, loyal customers and new interlocutors. 

The brand visibility strategy went hand in hand with an ad-hoc plan aimed at shortening the distances with its partners and at outlining common future developments. 
The 4 "Partners Meetings" organised during the year by the company are part of this direction. 

Testo a Destra
Immagine 30%/Testo 60%
Federico Castellani - ASA Sales Manager

“These meetings were essential not only to present new devices, but also to gather important inputs from our collaborators and to openly discuss the future. Their perception is crucial to improving our products and services and to considering new areas of development”, comments Federico Castellani, ASA Commercial Director.

You might also be interested in ...

See all articles

El.En. e ASA unite nello sviluppo tecnologico
News - 09/12/2024
Research and Development are the pillars on which all the companies of the El.En. Group base their growth: technological innovation, continuous training and know-how sharing are the key words that...
MLS Laser Therapy Workshop @ Melbourne
News - 28/11/2024
Two days of analysis and seminars focused on MLS® Laser Therapy with the support of laser therapy authorities.
Gruppo El.En and POLIMI @ASA
News - 26/11/2024
“Leadership: managing relationships and company values” is the training course born from the will of El.En., Deka, Quanta Systems, Cutlite Penta and ASA. 
Press - 23/01/2025
Anti-inflammatory, muscle relaxant and effective in rapidly reducing pain, MLS® Laser Therapy is the recommended therapy to successfully treat various muscular diseases.
Press - 23/01/2025
New valuable milestones for MLS® Laser Therapy, which is confirmed as a decisive therapy in pain management.
 Diabetic Peripheral Neuropathic Pain Using MiS MLS Laser
Blog - 23/01/2025
This clinical case highlights the effectiveness of using the MiS laser device on a 67-year-old woman who was diagnosed with type II diabetes mellitus in 2008.